Trinity Biotech | TRIB - أصول متداولة





أصول متداولة تغيير تاريخ
Abbott USD 23.5B 1.02B 2026-09
Bayer EUR 39.6B 5.96B 2026-09
Bio-Rad Laboratories USD 3.08B 58.1M 2026-09
EDAP TMS EUR 50.36M 6.01M 2026-03
J&J USD 56.35B 3.42B 2026-09
Mesa Laboratories USD 105.63M 8.2M 2025-12
OraSure Technologies USD 222.94M 17.84M 2026-06
Plus Therapeutics USD 11.77M 6.26M 2026-06
Roche Holding CHF 35.44B 3.29B 2026-06
Siemens EUR 68.86B 3.72B 2026-09
Thermo Fisher Scientific USD 25.62B 2.25B 2026-09
Tosoh JPY 848.95B 13.59B 2026-09
Trinity Biotech USD 31.36M 4.54M 2026-03
Veracyte USD 467.88M 106.9M 2026-09